These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16461359)

  • 1. A novel GTPase, CRAG, mediates promyelocytic leukemia protein-associated nuclear body formation and degradation of expanded polyglutamine protein.
    Qin Q; Inatome R; Hotta A; Kojima M; Yamamura H; Hirai H; Yoshizawa T; Tanaka H; Fukami K; Yanagi S
    J Cell Biol; 2006 Feb; 172(4):497-504. PubMed ID: 16461359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promyelocytic leukemia protein is redistributed during the formation of intranuclear inclusions independent of polyglutamine expansion: an immunohistochemical study on Marinesco bodies.
    Kumada S; Uchihara T; Hayashi M; Nakamura A; Kikuchi E; Mizutani T; Oda M
    J Neuropathol Exp Neurol; 2002 Nov; 61(11):984-91. PubMed ID: 12430715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional repression and cell death induced by nuclear aggregates of non-polyglutamine protein.
    Fu L; Gao YS; Sztul E
    Neurobiol Dis; 2005 Dec; 20(3):656-65. PubMed ID: 15964198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nucleolar targeting signal in PML-I addresses PML to nucleolar caps in stressed or senescent cells.
    Condemine W; Takahashi Y; Le Bras M; de Thé H
    J Cell Sci; 2007 Sep; 120(Pt 18):3219-27. PubMed ID: 17878236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRMP5-associated GTPase (CRAG) protein protects neuronal cells against cytotoxicity of expanded polyglutamine protein partially via c-Fos-dependent activator protein-1 activation.
    Nagashima S; Fukuda T; Kubota Y; Sugiura A; Nakao M; Inatome R; Yanagi S
    J Biol Chem; 2011 Sep; 286(39):33879-89. PubMed ID: 21832068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PML clastosomes prevent nuclear accumulation of mutant ataxin-7 and other polyglutamine proteins.
    Janer A; Martin E; Muriel MP; Latouche M; Fujigasaki H; Ruberg M; Brice A; Trottier Y; Sittler A
    J Cell Biol; 2006 Jul; 174(1):65-76. PubMed ID: 16818720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient mutations alter ATRX targeting to PML nuclear bodies.
    Bérubé NG; Healy J; Medina CF; Wu S; Hodgson T; Jagla M; Picketts DJ
    Eur J Hum Genet; 2008 Feb; 16(2):192-201. PubMed ID: 17957225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3.
    Fu C; Ahmed K; Ding H; Ding X; Lan J; Yang Z; Miao Y; Zhu Y; Shi Y; Zhu J; Huang H; Yao X
    Oncogene; 2005 Aug; 24(35):5401-13. PubMed ID: 15940266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Puromycin-based vectors promote a ROS-dependent recruitment of PML to nuclear inclusions enriched with HSP70 and Proteasomes.
    Moran DM; Shen H; Maki CG
    BMC Cell Biol; 2009 May; 10():32. PubMed ID: 19409099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation.
    Tatham MH; Geoffroy MC; Shen L; Plechanovova A; Hattersley N; Jaffray EG; Palvimo JJ; Hay RT
    Nat Cell Biol; 2008 May; 10(5):538-46. PubMed ID: 18408734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-induced antiviral Mx1 GTPase is associated with components of the SUMO-1 system and promyelocytic leukemia protein nuclear bodies.
    Engelhardt OG; Ullrich E; Kochs G; Haller O
    Exp Cell Res; 2001 Dec; 271(2):286-95. PubMed ID: 11716541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleus accumbens associated 1 is recruited within the promyelocytic leukemia nuclear body through SUMO modification.
    Tatemichi Y; Shibazaki M; Yasuhira S; Kasai S; Tada H; Oikawa H; Suzuki Y; Takikawa Y; Masuda T; Maesawa C
    Cancer Sci; 2015 Jul; 106(7):848-56. PubMed ID: 25891951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the Zac1's transactivation and coactivation functions via PML and Daxx within distinct subcellular localizations.
    Ho CL; Huang YC; Tai CK; Liu ST; Wang JK; Wang WM; Huang SM
    Int J Biochem Cell Biol; 2010 Jun; 42(6):902-10. PubMed ID: 20097304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calpain 5 is highly expressed in the central nervous system (CNS), carries dual nuclear localization signals, and is associated with nuclear promyelocytic leukemia protein bodies.
    Singh R; Brewer MK; Mashburn CB; Lou D; Bondada V; Graham B; Geddes JW
    J Biol Chem; 2014 Jul; 289(28):19383-94. PubMed ID: 24838245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleocytoplasmic shuttling of p62/SQSTM1 and its role in recruitment of nuclear polyubiquitinated proteins to promyelocytic leukemia bodies.
    Pankiv S; Lamark T; Bruun JA; Øvervatn A; Bjørkøy G; Johansen T
    J Biol Chem; 2010 Feb; 285(8):5941-53. PubMed ID: 20018885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are promyelocytic leukaemia protein nuclear bodies a scaffold for caspase-2 programmed cell death?
    Sanchez-Pulido L; Valencia A; Rojas AM
    Trends Biochem Sci; 2007 Sep; 32(9):400-6. PubMed ID: 17693089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Entrapment of viral capsids in nuclear PML cages is an intrinsic antiviral host defense against varicella-zoster virus.
    Reichelt M; Wang L; Sommer M; Perrino J; Nour AM; Sen N; Baiker A; Zerboni L; Arvin AM
    PLoS Pathog; 2011 Feb; 7(2):e1001266. PubMed ID: 21304940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal intranuclear inclusion disease without polyglutamine inclusions in a child.
    McFadden K; Hamilton RL; Insalaco SJ; Lavine L; Al-Mateen M; Wang G; Wiley CA
    J Neuropathol Exp Neurol; 2005 Jun; 64(6):545-52. PubMed ID: 15977647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lentivector-mediated rescue from cerebellar ataxia in a mouse model of spinocerebellar ataxia.
    Torashima T; Koyama C; Iizuka A; Mitsumura K; Takayama K; Yanagi S; Oue M; Yamaguchi H; Hirai H
    EMBO Rep; 2008 Apr; 9(4):393-9. PubMed ID: 18344973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PML nuclear bodies and neuronal intranuclear inclusion in polyglutamine diseases.
    Takahashi J; Fujigasaki H; Iwabuchi K; Bruni AC; Uchihara T; El Hachimi KH; Stevanin G; Dürr A; Lebre AS; Trottier Y; de Thé H; Tanaka J; Hauw JJ; Duyckaerts C; Brice A
    Neurobiol Dis; 2003 Aug; 13(3):230-7. PubMed ID: 12901837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.